Find a Clinical Trial
Filter
DEFENDO Long-Term Follow-Up Study
Neurotrophic keratitis
All genders
18+
Recruiting now
Department of Ophthalmology
SEER-2
Neurotrophic keratitis
All genders
18+
Recruiting now
Department of Ophthalmology
POETYK SjS-1
Sjogren's syndrome
All genders
18+
Recruiting now
Department of Ophthalmology
A Study of Sargramostim Plus Pembrolizumab With or Without Pemetrexed in Patients With Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy
Non-small cell lung cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Division of Thoracic Surgery
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
BALATON
Macular degeneration
All genders
18+
Recruiting now
Department of Ophthalmology
Belvedere
Macular degeneration
All genders
50+
Recruiting now
Department of Ophthalmology
To Evaluate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC
Small cell lung cancer
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
KPI-012-C-001
Corneal disorders
All genders
18+
Recruiting now
Department of Ophthalmology
Discovery
Glaucoma
All genders
No minimum age
Recruiting now
Department of Ophthalmology